9
www.technavio.com enquiry@technavio .com Infectious Diseases Market in US 2015- 2019

Infectious Diseases Market in US 2015-2019

Embed Size (px)

Citation preview

[email protected]

Infectious Diseases Market in US 2015-2019

Covered in this Report

• This report covers the present scenario and the growth prospects of the infectious diseases market in US for the period 2015-2019.

• o calculate the market size, the report considers revenue generated through the sales of drugs administered to treat infectious diseases caused by bacteria, viruses, fungi, and parasites.

• Technavio's report, Infectious Diseases Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

• In addition, it discusses the major drivers that influence the growth of the market, challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market.

Infectious Diseases Market in US 2015-2019

USA – CANADA – UK – CHINA – INDIA

Market Overview• Human beings are prone to various kinds of infections.

• Infectious diseases are caused by various pathogenic microorganisms such as bacteria, fungi, parasites, and viruses.

• Antimicrobials are used to treat infections. They act by killing or resisting the growth of the microorganisms.

• They either act via the host defense system or directly target the causative agent.

• Based on the target organism, antimicrobials can be classified into anti-bacterial, anti-viral, anti-fungal, and anti-parasitic drugs.

• Technavio's analysts forecast the infectious diseases market in US to grow at a CAGR of 3.37% over the period 2014-2019.

To know more aboutInfectious Diseases

Market in US 2015-2019,please mail us at

[email protected]

USA – CANADA – UK – CHINA – INDIA

Key Findings

• Pharmaceutical companies are forming strategic alliances and undergoing collaborative agreements and M&A to increase their market share.

• For instance, in January 2012, the Bill & Melinda Gates Foundation, the UAE, the US, and the UK governments, the World Bank, 13 pharmaceutical companies, and global health organizations collaborated with the aim to abolish and accelerate the control of 10 neglected tropical diseases by 2020.

• M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company.

• The early detection of infections is important to reduce the chances of disease severity.

USA – CANADA – UK – CHINA – INDIA

Key Questions Answered in Our Report

• What will the market size be in 2019 and what will the growth rate be?

• What are the key market trends?

• What is driving this market?

• What are the challenges to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities and threats faced by the key vendors?

• What are the strengths and weaknesses of the key vendors?

Have a question of your own about this report?

Ask our Analysts

USA – CANADA – UK – CHINA – INDIA

• Decision makers and influencers in sales & marketing, strategy, product and R&D teams rely on research from Technavio. We have a large and growing base of happy customers worldwide. Our customers include technology suppliers, end users, consulting companies, investment firms and research institutes.

• Technavio was founded in 2003 in London. We have about 300 analysts globally. We cover more than 500 technologies across 80 countries. Traditional media such as Forbes Asia and New York Times, along with other web media portals, like to quote us.

About Technavio

Some of our clients include:ACT Global, Flextronics, Huawei Technologies Co, Infosys, Harris Corporation, Infosys, Intercad, Hidaka Precision Tools & Dies Company, Huawei Technologies Co, American Capital, Analysis Group, Netscout, NTT DoCoMo

USA – CANADA – UK – CHINA – INDIA

Thank You!

Mail us at: [email protected] can visit us at:www.technavio.com

USA – CANADA – UK – CHINA – INDIA